Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Samuel García-Esteve"'
Autor:
Natalia Jiménez, Òscar Reig, Mercedes Marín-Aguilera, Caterina Aversa, Laura Ferrer-Mileo, Albert Font, Alejo Rodriguez-Vida, Miguel Ángel Climent, Sara Cros, Isabel Chirivella, Montserrat Domenech, Mariona Figols, Enrique González-Billalabeitia, Daniel Jiménez Peralta, Leonardo Rodríguez-Carunchio, Samuel García-Esteve, Marta Garcia de Herreros, Maria J. Ribal, Aleix Prat, Begoña Mellado
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4757
Cancers
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Scientia
Cancers
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Scientia
Simple Summary The combination of androgen deprivation therapy (ADT) with docetaxel (DX) or/and with novel anti-androgen receptor therapies have become standards for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de97278051a48f493c71bdcd4a4908a
http://hdl.handle.net/2445/197342
http://hdl.handle.net/2445/197342
Autor:
Laia Fernandez-Mañas, Laura Gonzalez Aguado, Caterina Aversa, Laura Ferrer-Mileo, Marta Garcia de Herreros, Natalia Jiménez, Albert Febrer, Roger Vernet, Samuel García-Esteve, Begona Mellado, Oscar Reig Torras
Publikováno v:
Journal of Clinical Oncology. 41:681-681
681 Background: Immune checkpoint inhibitors (ICI) are the standard of care for metastatic renal cell carcinoma (mRCC). Circadian rhythm drives organisms to properly predict and react to cyclical changes in the environment, and also affects the adapt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eab25454c80e6fbd7a3c1bf9552019e2
https://doi.org/10.1200/jco.2023.41.6_suppl.681
https://doi.org/10.1200/jco.2023.41.6_suppl.681
Autor:
Oscar Reig Torras, Natalia Jiménez, Marta Garcia de Herreros, Caterina Aversa, Mercedes Marin, Laura Ferrer, Leonardo Rodriguez-Carunchio, Isabel Trias, Laia Fernandez-Mañas, Samuel García-Esteve, Albert Font Pous, Alejo Rodriguez-Vida, Montserrat Domenech-Santasusana, Mariona Figols, Miguel Ángel Climent, Sara Cros Costa, Isabel Chirivella, Daniel Herrero Rivera, Cristina Suárez, Begoña Mellado-Gonzalez
Publikováno v:
Journal of Clinical Oncology. 41:236-236
236 Background: Alterations on the tumor suppressor genes (TSG) RB1, PTEN and TP53 are associated with treatment resistance and aggressive clinical evolution of prostate cancer patients (pts). We developed and assessed the role of a TSG gene expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::150f96adcfc96ebc7f778733663933e6
https://doi.org/10.1200/jco.2023.41.6_suppl.236
https://doi.org/10.1200/jco.2023.41.6_suppl.236